This page lists the SEC filings reported by VIKING GLOBAL INVESTORS LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2022-11-10 | VIKING GLOBAL INVESTORS LP | Cazoo Group Ltd | 60,000,000 | 7.3% | EDGAR |
| SC 13D | 2022-11-03 | VIKING GLOBAL INVESTORS LP | Frazier Lifesciences Acquisition Corp | 3,671,462 | 25.7% | EDGAR |
| SC 13G | 2022-11-02 | VIKING GLOBAL INVESTORS LP | Frazier Lifesciences Acquisition Corp | 2,824,400 | 19.8% | EDGAR |
| SC 13G | 2022-10-07 | VIKING GLOBAL INVESTORS LP | Trevi Therapeutics, Inc. | 5,984,734 | 10.0% | EDGAR |
| SC 13D | 2022-09-19 | VIKING GLOBAL INVESTORS LP | Cazoo Group Ltd | 60,000,000 | 7.3% | EDGAR |
| SC 13G/A | 2022-09-12 | VIKING GLOBAL INVESTORS LP | Amylyx Pharmaceuticals, Inc. | 5,770,536 | 9.9% | EDGAR |
| SC 13G | 2022-07-01 | VIKING GLOBAL INVESTORS LP | Ginkgo Bioworks Holdings, Inc. | 115,084,128 | 9.7% | EDGAR |
| SC 13G | 2022-06-10 | VIKING GLOBAL INVESTORS LP | Celldex Therapeutics, Inc. | 2,366,385 | 5.1% | EDGAR |
| SC 13G | 2022-05-20 | VIKING GLOBAL INVESTORS LP | PepGen Inc. | 1,793,923 | 8.0% | EDGAR |
| SC 13G | 2022-04-14 | VIKING GLOBAL INVESTORS LP | STANDARD BIOTOOLS INC. | 8,103,527 | 9.5% | EDGAR |
| SC 13G/A | 2022-03-22 | VIKING GLOBAL INVESTORS LP | PROCEPT BioRobotics Corp | 3,658,892 | 8.4% | EDGAR |
| SC 13D/A | 2022-03-04 | VIKING GLOBAL INVESTORS LP | Ginkgo Bioworks Holdings, Inc. | 51,055,144 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | Coupa Software Inc | 4,168,030 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | AbCellera Biologics Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | Zentalis Pharmaceuticals, Inc. | 2,118,284 | 4.7% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | Talaris Therapeutics, Inc. | 3,289,617 | 8.0% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | Rallybio Corp | 4,194,777 | 13.1% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | PMV Pharmaceuticals, Inc. | 1,790,284 | 3.9% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | PROCEPT BioRobotics Corp | 4,907,892 | 11.3% | EDGAR |
| SC 13G/A | 2022-02-14 | VIKING GLOBAL INVESTORS LP | Pharvaris N.V. | 2,455,536 | 7.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.